RGNX
Price:
$7.8
Market Cap:
$403.24M
REGENXBIO Inc. is a biotechnology company operating in the clinical stage, dedicated to developing gene therapy candidates. These therapies are designed to introduce genes into cells, aiming either to rectify genetic deficiencies or to stimulate the body's own cells to produce therapeutic proteins or antibodies to combat diseases. Central to its therapeutic development is the proprietary NAV Technology Platform, an adeno-associated virus-based gene delivery system. The company's primary investigational asset, RGX-314, is currently in Phase III clinical trials for treating wet age-related macular degeneration. Its pipeline also includes RGX-121 and RGX-111, both in Phase I/II trials for mucop...[Read more]
Industry
Biotechnology
IPO Date
2015-09-17
Stock Exchange
NASDAQ
Ticker
RGNX
According to REGENXBIO Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 459.08M. This represents a change of -29.25% compared to the average of 648.85M of the last 4 quarters.
The mean historical Enterprise Value of REGENXBIO Inc. over the last ten years is 1.01B. The current 459.08M Enterprise Value has changed 4.46% with respect to the historical average. Over the past ten years (40 quarters), RGNX's Enterprise Value was at its highest in in the September 2018 quarter at 2.41B. The Enterprise Value was at its lowest in in the June 2016 quarter at 180.81M.
Average
1.01B
Median
972.62M
Minimum
407.21M
Maximum
1.47B
Discovering the peaks and valleys of REGENXBIO Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 373.78%
Maximum Annual Enterprise Value = 1.47B
Minimum Annual Increase = -51.51%
Minimum Annual Enterprise Value = 407.21M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 968.70M | 137.89% |
| 2024 | 407.21M | -51.51% |
| 2023 | 839.79M | -14.00% |
| 2022 | 976.53M | -13.52% |
| 2021 | 1.13B | -20.77% |
| 2020 | 1.43B | -1.36% |
| 2019 | 1.44B | -1.43% |
| 2018 | 1.47B | 54.91% |
| 2017 | 946.35M | 103.50% |
| 2016 | 465.05M | 373.78% |
The current Enterprise Value of REGENXBIO Inc. (RGNX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
738.57M
5-year avg
864.29M
10-year avg
1.01B
REGENXBIO Inc.’s Enterprise Value is less than Absci Corporation (1.15B), greater than Verastem, Inc. (205.50M), less than MoonLake Immunotherapeutics (1.22B), less than Olema Pharmaceuticals, Inc. (779.08M), greater than 4D Molecular Therapeutics, Inc. (453.04M), less than Ventyx Biosciences, Inc. (982.56M), greater than Prothena Corporation plc (145.71M), less than Corvus Pharmaceuticals, Inc. (962.25M), less than KalVista Pharmaceuticals, Inc. (1.49B), greater than Gossamer Bio, Inc. (201.31M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.15B | $1.16B | |
| 205.50M | $285.57M | |
| 1.22B | $1.41B | |
| 779.08M | $830.67M | |
| 453.04M | $504.99M | |
| 982.56M | $1.00B | |
| 145.71M | $467.51M | |
| 962.25M | $1.00B | |
| 1.49B | $1.44B | |
| 201.31M | $39.40M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like REGENXBIO Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like REGENXBIO Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is REGENXBIO Inc.'s Enterprise Value?
What is the highest Enterprise Value for REGENXBIO Inc. (RGNX)?
What is the 3-year average Enterprise Value for REGENXBIO Inc. (RGNX)?
What is the 5-year average Enterprise Value for REGENXBIO Inc. (RGNX)?
How does the current Enterprise Value for REGENXBIO Inc. (RGNX) compare to its historical average?